PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ·Healthcare·Biotechnology
$1.44
-0.35%
Mkt Cap $76.79M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 6, 2026 | — | — | — | -$0.40 | -$0.34 | +15.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.40 | -$0.40 | +0.00% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.39 | -$0.41 | -5.13% | — | — |
| Q2 2025 May 9, 2025 | — | — | — | -$0.37 | -$0.34 | +8.11% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.38 | -$0.45 | -18.42% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.35 | -$0.37 | -5.71% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.34 | -$0.02 | +94.12% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.35 | -$0.30 | +14.29% | — | — |
| Q1 2024 Feb 29, 2024 | — | — | — | -$0.39 | -$0.31 | +20.51% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.45 | -$0.34 | +24.44% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.47 | -$0.38 | +19.15% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$0.48 | -$0.42 | +12.50% | — | — |
| Q1 2023 Mar 1, 2023 | — | — | — | -$0.44 | -$0.43 | +2.27% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.42 | -$0.40 | +4.76% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.41 | -$0.38 | +7.32% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.42 | -$0.41 | +2.38% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$0.35 | -$0.41 | -17.14% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.31 | -$0.33 | -6.45% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$0.29 | -$0.29 | +0.00% | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$0.26 | -$0.26 | +0.00% | — | — |